Abstract: Disclosed are a degradable lost circulation material for protecting oil and gas reservoirs, and a preparation method and use thereof, belonging to the technical field of petrochemicals. The degradable lost circulation material includes an epoxidized vanillin Schiff base compound and a composite curing agent, the composite curing agent including an anhydride curing agent and an imidazole curing agent, wherein the epoxidized vanillin Schiff base compound has a structure shown in formula I.

Abstract: The present disclosure provides a Pseudoalteromonas agarivorans strain and a preparation method of an exopolysaccharide (EPS), and relates to the technical field of functional bacteria. In the present disclosure, the Pseudoalteromonas agarivorans strain HJWL2022 has a deposit number of CGMCC No. 26272. Fermentation, centrifugation, alcohol precipitation, protein removal, purification, and drying are conducted with the strain HJWL2022 to obtain a pure EPS. A proportion of a monosaccharide component in the product EPS is controlled by precisely controlling a pH value in a fermentation environment of the strain HJWL2022. Targeted control of a monosaccharide ratio is achieved to enhance a certain biological activity by adjusting fermentation conditions to change a composition of a bacterial EPS.

Abstract: The disclosure discloses a fatty acid synthase inhibitor and application thereof and belongs to the technical field of medical biology. The fatty acid synthase inhibitor of the disclosure can significantly inhibit the activity of fatty acid synthase without affecting normal expression, and adjust the ratio of fatty acids in cells. The fatty acid synthase inhibitor of the disclosure has a good tumor proliferation inhibitory effect, can arrest the growth cycle of tumor cells in the interphase, prevent tumor cell division, inhibit tumor cell proliferation, promote tumor cell apoptosis and exert a tumor treatment effect, can be used to treat tumors and metabolism related diseases, and has an important clinical application prospect.

Abstract: The disclosure discloses a fatty acid synthase inhibitor and application thereof and belongs to the technical field of medical biology. The fatty acid synthase inhibitor of the disclosure can significantly inhibit the activity of fatty acid synthase without affecting normal expression, and adjust the ratio of fatty acids in cells. The fatty acid synthase inhibitor of the disclosure has a good tumor proliferation inhibitory effect, can arrest the growth cycle of tumor cells in the interphase, prevent tumor cell division, inhibit tumor cell proliferation, promote tumor cell apoptosis and exert a tumor treatment effect, can be used to treat tumors and metabolism related diseases, and has an important clinical application prospect.